Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 13-16 January 2025
Medicines containing semaglutide: PRAC investigating risk of rare eye conditionPRAC will assess risk of non-arteritic anterior ischemic optic neuropathy (NAION)EMA’s safety…, Agenda Agenda of the PRAC meeting 13-16 January 2025DraftReference Number: EMA/PRAC/549682/2024 English (EN…, PRAC statistics: January 2025 , PRAC statistics: January 2025 English (EN) (107.97 KB - PDF)First published: 17/01/2025View, Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association…, Ongoing referrals ProcedureStatusUpdateFinasteride- and dutasteride-containing medicinal products - referralUnder evaluationPRAC continued its…
Medicines containing semaglutide: PRAC investigating risk of rare eye conditionPRAC will assess risk of non-arteritic anterior ischemic optic neuropathy (NAION)EMA’s safety…, Agenda Agenda of the PRAC meeting 13-16 January 2025DraftReference Number: EMA/PRAC/549682/2024 English (EN…, PRAC statistics: January 2025 , PRAC statistics: January 2025 English (EN) (107.97 KB - PDF)First published: 17/01/2025View, Glossary Safety signal assessments. A safety signal is information which suggests a new potentially causal association, or a new aspect of a known association…, Ongoing referrals ProcedureStatusUpdateFinasteride- and dutasteride-containing medicinal products - referralUnder evaluationPRAC continued its…
